PeptideWiki
Research OnlyKhavinson Organ Bioregulator Anti-Aging & Longevity

Livagen

Also known as: KEDA tetrapeptide · Lys-Glu-Asp-Ala · Liver peptide bioregulator

A synthetic tetrapeptide (Lys-Glu-Asp-Ala) from the Khavinson bioregulator series that de-heterochromatinizes age-condensed chromatin in lymphocytes, restoring youthful gene expression patterns. Hepatoprotective and immunomodulatory. One of the most mechanistically unique anti-aging peptides — it directly reactivates genes silenced by chromatin condensation with age.

What is Livagen? A synthetic tetrapeptide (Lys-Glu-Asp-Ala) from the Khavinson bioregulator series that de-heterochromatinizes age-condensed chromatin in lymphocytes, restoring youthful gene expression patterns. Hepatoprotective and immunomodulatory. One of the most mechanistically unique anti-aging peptides — it directly reactivates genes silenced by chromatin condensation with age.

How does Livagen work? Livagen penetrates cell nuclei and binds to condensed chromatin regions (heterochromatin) that have been silenced with aging, particularly histone H1-DNA interactions. This de-condensation reactivates ribosomal genes and other age-silenced transcriptional programs. In human lymphocyte cultures, Livagen restores ribosomal RNA synthesis rates to youthful levels within 24 hours. Also has hepatoprotective effects via anti-apoptotic signaling in liver cells.

Benefits of Livagen: Unique mechanism: directly de-condenses age-silenced chromatin; Reactivates ribosomal genes and silenced transcription; Restores youthful gene expression in lymphocytes; Hepatoprotective and anti-apoptotic in liver; Immunomodulatory via lymphocyte activation; Anti-aging at the fundamental epigenetic level; Synergistic with other anti-aging peptide bioregulators

Livagen dosage: Standard Khavinson protocol: 1-2mg/day subcutaneous or IM for 10 days, 1-2x per year.

Research status: Research Only

Source: PeptideWiki — https://www.peptide-wiki.net/peptides/livagen

4 AAs
MW: 447.49 Da
CAS: 137562-23-3

Mechanism of Action

Livagen penetrates cell nuclei and binds to condensed chromatin regions (heterochromatin) that have been silenced with aging, particularly histone H1-DNA interactions. This de-condensation reactivates ribosomal genes and other age-silenced transcriptional programs. In human lymphocyte cultures, Livagen restores ribosomal RNA synthesis rates to youthful levels within 24 hours. Also has hepatoprotective effects via anti-apoptotic signaling in liver cells.

Benefits

  • Unique mechanism: directly de-condenses age-silenced chromatin
  • Reactivates ribosomal genes and silenced transcription
  • Restores youthful gene expression in lymphocytes
  • Hepatoprotective and anti-apoptotic in liver
  • Immunomodulatory via lymphocyte activation
  • Anti-aging at the fundamental epigenetic level
  • Synergistic with other anti-aging peptide bioregulators

Side Effects & Risks

  • Limited standalone clinical data beyond Russian research
  • Well tolerated in available studies
  • Injection site reactions

Storage & Reconstitution Guide

Storage Temperature

-20°C (lyophilized)

24 months (lyophilized), 28 days (reconstituted)

Reconstitution Solvent

Bacteriostatic water (BAC water)

Swirl gently — do not shake or vortex

Handling Notes

Protect lyophilized peptide from moisture and light. Once reconstituted, keep refrigerated. Discard if solution becomes cloudy or discolored. Use insulin syringe for precise dosing.

Step-by-Step Reconstitution

1

Gather supplies

BAC water, insulin syringe, alcohol swabs, vial

2

Disinfect tops

Swab rubber stoppers of both vials with alcohol

3

Draw BAC water

Pull desired mL of BAC water into syringe

4

Inject slowly

Inject BAC water down the side of the peptide vial, swirl gently to dissolve

Research Protocol

Dose Range
1–2 mg
Frequency
Daily injection for 10-day courses
Cycle
10-day courses, 1-2x per year
Routes
subcutaneous injection
Notes
Standard Khavinson protocol: 1-2mg/day subcutaneous or IM for 10 days, 1-2x per year.
Open Dosage Calculator →

Legal & Regulatory Status

Research StatusResearch Only
WADA Status Not Listed
FDA ClassificationNot Approved
Originsynthetic

Sold for research purposes only. Not for human use. Laws vary by country.

Commonly Stacked With

View all peptide stacks →

External Resources

Chemical Properties

CAS Number
137562-23-3
Mol. Weight
447.49 Da
Formula
C18H33N5O7
PW

PeptideWiki Research Team

Evidence-based research data sourced from PubMed and ClinicalTrials.gov · Last updated: February 25, 2026

Cite: PeptideWiki. “Livagen.” peptide-wiki.net/peptides/livagen. Accessed 2026.

Frequently Asked Questions About Livagen

What is Livagen?

A synthetic tetrapeptide (Lys-Glu-Asp-Ala) from the Khavinson bioregulator series that de-heterochromatinizes age-condensed chromatin in lymphocytes, restoring youthful gene expression patterns. Hepatoprotective and immunomodulatory. One of the most mechanistically unique anti-aging peptides — it directly reactivates genes silenced by chromatin condensation with age.

What are the benefits of Livagen?

Unique mechanism: directly de-condenses age-silenced chromatin

What are the benefits of Livagen?

Reactivates ribosomal genes and silenced transcription

What are the side effects of Livagen?

Limited standalone clinical data beyond Russian research

What is the recommended dosage for Livagen?

Standard Khavinson protocol: 1-2mg/day subcutaneous or IM for 10 days, 1-2x per year.

How long should a Livagen cycle last?

10-day courses, 1-2x per year

More Anti-Aging & Longevity Peptides

View all Anti-Aging & Longevity peptides →